JAMES C GALE Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JAMES C GALE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JAMES C GALE. JAMES C GALE is Director in RELM WIRELESS CORP ($RELM.OB) and Director in Teligent, Inc. ($TLGT) and Director in Endo Pharmaceuticals Solutions Inc. ($IDEV) and Director in Valera Pharmaceuticals Inc ($VLRX) and Director in Pfenex Inc. ($PFNX).
Latest Insider Trading Transactions of JAMES C GALE
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, RELM.OB, IDEV, PFNX, TLGT, VLRX
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 03 2020 | TLGT | Teligent, Inc. | GALE JAMES C | Director | Option Exercise | A | 0.42 | 20,000 | 8,300 | 20,000 | |
Oct 04 2019 | TLGT | Teligent, Inc. | GALE JAMES C | Director | Option Exercise | A | 0.88 | 10,653 | 9,375 | 10,653 | |
Jul 03 2019 | TLGT | Teligent, Inc. | GALE JAMES C | Director | Option Exercise | A | 0.65 | 14,423 | 9,375 | 14,423 | |
Jul 03 2019 | TLGT | Teligent, Inc. | GALE JAMES C | Director | Option Exercise | A | 0.65 | 14,423 | 9,375 | 14,423 | |
May 31 2019 | TLGT | Teligent, Inc. | GALE JAMES C | Director | Buy | P | 0.66 | 20,000 | 13,166 | 394,624 | 374.6 K to 394.6 K (+5.34 %) |
May 24 2019 | TLGT | Teligent, Inc. | GALE JAMES C | Director | Buy | P | 0.69 | 20,000 | 13,814 | 374,624 | 354.6 K to 374.6 K (+5.64 %) |
May 15 2019 | TLGT | Teligent, Inc. | GALE JAMES C | Director | Option Exercise | A | 0.86 | 10,901 | 9,375 | 10,901 | |
May 15 2019 | TLGT | Teligent, Inc. | GALE JAMES C | Director | Option Exercise | A | 0.86 | 10,901 | 9,375 | 10,901 | |
Jan 04 2019 | TLGT | Teligent, Inc. | GALE JAMES C | Director | Option Exercise | A | 1.32 | 20,000 | 26,400 | 20,000 | |
Jan 04 2018 | TLGT | Teligent, Inc. | GALE JAMES C | Director | Option Exercise | A | 3.85 | 20,000 | 77,000 | 20,000 | |
Nov 13 2017 | TLGT | Teligent, Inc. | GALE JAMES C | Director | Buy | P | 3.81 | 15,000 | 57,137 | 354,624 | 339.6 K to 354.6 K (+4.42 %) |
Jan 05 2017 | TLGT | Teligent, Inc. | GALE JAMES C | Director | Option Exercise | A | 7.05 | 20,000 | 141,000 | 20,000 | |
Mar 14 2016 | TLGT | Teligent, Inc. | GALE JAMES C | Director | Buy | P | 4.91 | 15,000 | 73,718 | 25,000 | 10 K to 25 K (+150.00 %) |
Jan 06 2016 | TLGT | Teligent, Inc. | GALE JAMES C | Director | Option Exercise | A | 8.81 | 20,000 | 176,200 | 20,000 | |
May 01 2015 | TLGT | Teligent, Inc. | GALE JAMES C | Director | Buy | P | 5.04 | 10,000 | 50,400 | 49,624 | 39.6 K to 49.6 K (+25.24 %) |
May 01 2015 | TLGT | Teligent, Inc. | GALE JAMES C | Director | Buy | P | 5.04 | 20,000 | 100,800 | 39,624 | 19.6 K to 39.6 K (+101.92 %) |
Apr 30 2015 | PFNX | Pfenex Inc. | GALE JAMES C | Director | Sell | S | 14.57 | 330,959 | 4,822,073 | 592,978 | 923.9 K to 593 K (-35.82 %) |
Apr 30 2015 | PFNX | Pfenex Inc. | GALE JAMES C | Director | Sell | S | 14.57 | 1,576,808 | 22,974,093 | 1,818,339 | 3.4 M to 1.8 M (-46.44 %) |
Mar 12 2008 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
Dec 19 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | J | 0.00 | 122,725 | 0 | 568,562 | 691.3 K to 568.6 K (-17.75 %) |
Dec 19 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | J | 0.00 | 172,788 | 0 | 738,317 | 911.1 K to 738.3 K (-18.96 %) |
Dec 19 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | J | 0.00 | 215,885 | 0 | 421,191 | 637.1 K to 421.2 K (-33.89 %) |
Oct 23 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.90 | 302,868 | 2,392,657 | 691,287 | 994.2 K to 691.3 K (-30.46 %) |
Oct 23 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Buy | J | 7.09 | 101,371 | 719,025 | 994,155 | 892.8 K to 994.2 K (+11.35 %) |
Oct 23 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.90 | 395,292 | 3,122,807 | 911,105 | 1.3 M to 911.1 K (-30.26 %) |
Oct 23 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Buy | J | 7.09 | 133,604 | 947,653 | 1,306,397 | 1.2 M to 1.3 M (+11.39 %) |
Oct 23 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.90 | 634,217 | 5,010,314 | 765,858 | 1.4 M to 765.9 K (-45.30 %) |
Oct 23 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Buy | J | 7.09 | 205,306 | 1,456,235 | 1,400,075 | 1.2 M to 1.4 M (+17.18 %) |
Oct 23 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.90 | 36,048 | 284,779 | 32,947 | 69 K to 32.9 K (-52.25 %) |
Oct 23 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Buy | J | 7.09 | 10,120 | 71,781 | 69,015 | 58.9 K to 69 K (+17.18 %) |
Oct 23 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.90 | 160,256 | 1,266,022 | 146,556 | 306.8 K to 146.6 K (-52.23 %) |
Oct 23 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Buy | J | 7.09 | 44,990 | 319,114 | 306,812 | 261.8 K to 306.8 K (+17.18 %) |
Oct 23 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.90 | 819,821 | 6,476,586 | 749,734 | 1.6 M to 749.7 K (-52.23 %) |
Oct 23 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Buy | J | 7.09 | 230,130 | 1,632,312 | 1,569,555 | 1.3 M to 1.6 M (+17.18 %) |
Oct 23 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.90 | 151,498 | 1,196,834 | 290,045 | 441.5 K to 290 K (-34.31 %) |
Oct 23 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Buy | J | 7.09 | 46,696 | 331,215 | 441,543 | 394.8 K to 441.5 K (+11.83 %) |
Jun 18 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.30 | 1,017 | 7,424 | 589,917 | 590.9 K to 589.9 K (-0.17 %) |
Jun 18 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.30 | 15,790 | 115,267 | 590,934 | 606.7 K to 590.9 K (-2.60 %) |
Jun 18 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.30 | 1,341 | 9,789 | 777,501 | 778.8 K to 777.5 K (-0.17 %) |
Jun 18 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.30 | 20,811 | 151,920 | 778,842 | 799.7 K to 778.8 K (-2.60 %) |
Jun 18 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.30 | 2,061 | 15,045 | 1,194,769 | 1.2 M to 1.2 M (-0.17 %) |
Jun 18 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.30 | 31,980 | 233,454 | 1,196,830 | 1.2 M to 1.2 M (-2.60 %) |
Jun 18 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.30 | 102 | 745 | 58,895 | 59 K to 58.9 K (-0.17 %) |
Jun 18 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.30 | 1,576 | 11,505 | 58,997 | 60.6 K to 59 K (-2.60 %) |
Jun 18 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.30 | 452 | 3,300 | 261,822 | 262.3 K to 261.8 K (-0.17 %) |
Jun 18 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.30 | 7,008 | 51,158 | 262,274 | 269.3 K to 262.3 K (-2.60 %) |
Jun 18 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.30 | 2,300 | 16,790 | 1,339,425 | 1.3 M to 1.3 M (-0.17 %) |
Jun 18 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.30 | 34,725 | 253,493 | 1,341,725 | 1.4 M to 1.3 M (-2.52 %) |
Jun 18 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.30 | 427 | 3,117 | 247,347 | 247.8 K to 247.3 K (-0.17 %) |
Jun 18 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.30 | 7,610 | 55,553 | 247,774 | 255.4 K to 247.8 K (-2.98 %) |
Jun 07 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.36 | 7,763 | 57,106 | 633,114 | 640.9 K to 633.1 K (-1.21 %) |
Jun 07 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.35 | 37,563 | 276,035 | 640,877 | 678.4 K to 640.9 K (-5.54 %) |
Jun 07 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.36 | 10,218 | 75,166 | 835,484 | 845.7 K to 835.5 K (-1.21 %) |
Jun 07 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.35 | 49,507 | 363,807 | 845,702 | 895.2 K to 845.7 K (-5.53 %) |
Jun 07 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.36 | 15,702 | 115,507 | 1,301,883 | 1.3 M to 1.3 M (-1.19 %) |
Jun 07 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.35 | 76,077 | 559,059 | 1,317,585 | 1.4 M to 1.3 M (-5.46 %) |
Jun 07 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.36 | 774 | 5,694 | 63,211 | 64 K to 63.2 K (-1.21 %) |
Jun 07 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.35 | 3,750 | 27,557 | 63,985 | 67.7 K to 64 K (-5.54 %) |
Jun 07 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.36 | 3,441 | 25,313 | 281,017 | 284.5 K to 281 K (-1.21 %) |
Jun 07 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.35 | 16,671 | 122,509 | 284,458 | 301.1 K to 284.5 K (-5.54 %) |
Jun 07 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.36 | 17,532 | 128,969 | 1,436,173 | 1.5 M to 1.4 M (-1.21 %) |
Jun 07 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.35 | 84,986 | 624,528 | 1,453,705 | 1.5 M to 1.5 M (-5.52 %) |
Jun 07 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.36 | 3,253 | 23,930 | 270,273 | 273.5 K to 270.3 K (-1.19 %) |
Jun 07 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.35 | 15,760 | 115,814 | 273,526 | 289.3 K to 273.5 K (-5.45 %) |
Jun 11 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.35 | 26,427 | 194,201 | 606,687 | 633.1 K to 606.7 K (-4.17 %) |
Jun 11 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.35 | 34,831 | 255,959 | 800,653 | 835.5 K to 800.7 K (-4.17 %) |
Jun 11 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.35 | 53,524 | 393,326 | 1,248,359 | 1.3 M to 1.2 M (-4.11 %) |
Jun 11 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.35 | 2,638 | 19,386 | 60,573 | 63.2 K to 60.6 K (-4.17 %) |
Jun 11 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.35 | 11,729 | 86,192 | 269,288 | 281 K to 269.3 K (-4.17 %) |
Jun 11 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.35 | 59,763 | 439,174 | 1,376,410 | 1.4 M to 1.4 M (-4.16 %) |
Jun 11 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.35 | 11,088 | 81,481 | 259,185 | 270.3 K to 259.2 K (-4.10 %) |
Jun 06 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.35 | 13,214 | 97,124 | 678,440 | 691.7 K to 678.4 K (-1.91 %) |
Jun 06 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.39 | 25,350 | 187,215 | 691,681 | 717 K to 691.7 K (-3.54 %) |
Jun 06 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.35 | 17,415 | 128,002 | 895,209 | 912.6 K to 895.2 K (-1.91 %) |
Jun 06 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.39 | 33,411 | 246,747 | 912,624 | 946 K to 912.6 K (-3.53 %) |
Jun 06 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.35 | 26,762 | 196,703 | 1,393,662 | 1.4 M to 1.4 M (-1.88 %) |
Jun 06 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.39 | 51,342 | 379,171 | 14,204,424 | 14.3 M to 14.2 M (-0.36 %) |
Jun 06 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.35 | 1,319 | 9,695 | 67,735 | 69.1 K to 67.7 K (-1.91 %) |
Jun 06 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.39 | 2,531 | 18,692 | 69,054 | 71.6 K to 69.1 K (-3.54 %) |
Jun 06 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.35 | 5,865 | 43,108 | 301,129 | 307 K to 301.1 K (-1.91 %) |
Jun 06 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.39 | 11,251 | 83,091 | 306,994 | 318.2 K to 307 K (-3.54 %) |
Jun 06 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.35 | 29,881 | 219,628 | 1,538,691 | 1.6 M to 1.5 M (-1.90 %) |
Jun 06 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.39 | 57,326 | 423,364 | 1,568,572 | 1.6 M to 1.6 M (-3.53 %) |
Jun 06 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.35 | 5,544 | 40,749 | 289,286 | 294.8 K to 289.3 K (-1.88 %) |
Jun 06 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.39 | 10,636 | 78,549 | 294,830 | 305.5 K to 294.8 K (-3.48 %) |
May 30 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.32 | 25,952 | 189,969 | 745,309 | 771.3 K to 745.3 K (-3.36 %) |
May 30 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.31 | 9,005 | 65,800 | 771,261 | 780.3 K to 771.3 K (-1.15 %) |
May 30 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.32 | 34,204 | 250,373 | 983,305 | 1 M to 983.3 K (-3.36 %) |
May 30 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.31 | 11,868 | 86,719 | 1,017,509 | 1 M to 1 M (-1.15 %) |
May 30 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.32 | 52,560 | 384,739 | 1,525,889 | 1.6 M to 1.5 M (-3.33 %) |
May 30 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.31 | 18,238 | 133,265 | 1,578,449 | 1.6 M to 1.6 M (-1.14 %) |
May 30 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.32 | 2,591 | 18,966 | 74,408 | 77 K to 74.4 K (-3.36 %) |
May 30 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.31 | 899 | 6,569 | 76,999 | 77.9 K to 77 K (-1.15 %) |
May 30 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.32 | 11,518 | 84,312 | 330,795 | 342.3 K to 330.8 K (-3.36 %) |
May 30 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.31 | 3,997 | 29,206 | 342,313 | 346.3 K to 342.3 K (-1.15 %) |
May 30 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.32 | 58,686 | 429,582 | 1,689,847 | 1.7 M to 1.7 M (-3.36 %) |
May 30 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.31 | 20,364 | 148,800 | 1,748,533 | 1.8 M to 1.7 M (-1.15 %) |
May 30 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.32 | 10,889 | 79,707 | 317,330 | 328.2 K to 317.3 K (-3.32 %) |
May 30 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.31 | 3,778 | 27,606 | 328,219 | 332 K to 328.2 K (-1.14 %) |
Jun 01 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.40 | 13,183 | 97,558 | 717,031 | 730.2 K to 717 K (-1.81 %) |
Jun 01 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.35 | 15,095 | 110,997 | 730,214 | 745.3 K to 730.2 K (-2.03 %) |
Jun 01 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.40 | 17,375 | 128,580 | 946,035 | 963.4 K to 946 K (-1.80 %) |
Jun 01 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.35 | 19,895 | 146,292 | 963,410 | 983.3 K to 963.4 K (-2.02 %) |
Jun 01 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.40 | 23,551 | 174,284 | 1,471,766 | 1.5 M to 1.5 M (-1.57 %) |
Jun 01 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.35 | 30,572 | 224,802 | 1,495,317 | 1.5 M to 1.5 M (-2.00 %) |
Jun 01 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.40 | 1,316 | 9,739 | 71,585 | 72.9 K to 71.6 K (-1.81 %) |
Jun 01 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.35 | 1,507 | 11,081 | 72,901 | 74.4 K to 72.9 K (-2.03 %) |
Jun 01 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.40 | 5,851 | 43,299 | 318,245 | 324.1 K to 318.2 K (-1.81 %) |
Jun 01 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.35 | 6,699 | 49,259 | 324,096 | 330.8 K to 324.1 K (-2.03 %) |
Jun 01 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.40 | 29,814 | 220,633 | 1,625,898 | 1.7 M to 1.6 M (-1.80 %) |
Jun 01 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.35 | 34,135 | 251,001 | 1,655,712 | 1.7 M to 1.7 M (-2.02 %) |
Jun 01 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.40 | 5,531 | 40,931 | 305,466 | 311 K to 305.5 K (-1.78 %) |
Jun 01 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.35 | 6,333 | 46,568 | 310,997 | 317.3 K to 311 K (-2.00 %) |
May 29 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.37 | 1,321 | 9,736 | 780,266 | 781.6 K to 780.3 K (-0.17 %) |
May 29 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.36 | 7,737 | 56,913 | 781,587 | 789.3 K to 781.6 K (-0.98 %) |
May 29 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.36 | 3,628 | 26,718 | 789,324 | 793 K to 789.3 K (-0.46 %) |
May 29 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.36 | 22,106 | 162,702 | 792,952 | 815.1 K to 793 K (-2.71 %) |
May 29 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.37 | 1,742 | 12,839 | 1,028,377 | 1 M to 1 M (-0.17 %) |
May 29 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.36 | 10,197 | 75,008 | 1,030,119 | 1 M to 1 M (-0.98 %) |
May 29 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.36 | 4,782 | 35,216 | 1,040,316 | 1 M to 1 M (-0.46 %) |
May 29 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.36 | 29,136 | 214,444 | 1,045,098 | 1.1 M to 1 M (-2.71 %) |
May 29 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.37 | 2,676 | 19,722 | 1,580,287 | 1.6 M to 1.6 M (-0.17 %) |
May 29 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.36 | 15,669 | 115,260 | 1,582,963 | 1.6 M to 1.6 M (-0.98 %) |
May 29 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.36 | 7,348 | 54,113 | 1,598,632 | 1.6 M to 1.6 M (-0.46 %) |
May 29 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.36 | 44,772 | 329,526 | 1,605,980 | 1.7 M to 1.6 M (-2.71 %) |
May 29 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.37 | 132 | 973 | 77,898 | 78 K to 77.9 K (-0.17 %) |
May 29 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.36 | 772 | 5,679 | 78,030 | 78.8 K to 78 K (-0.98 %) |
May 29 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.36 | 362 | 2,666 | 78,802 | 79.2 K to 78.8 K (-0.46 %) |
May 29 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.36 | 2,207 | 16,244 | 79,164 | 81.4 K to 79.2 K (-2.71 %) |
May 29 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.37 | 586 | 4,319 | 346,310 | 346.9 K to 346.3 K (-0.17 %) |
May 29 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.36 | 3,434 | 25,260 | 346,890 | 350.3 K to 346.9 K (-0.98 %) |
May 29 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.36 | 1,610 | 11,857 | 350,324 | 351.9 K to 350.3 K (-0.46 %) |
May 29 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.36 | 9,811 | 72,210 | 351,934 | 361.7 K to 351.9 K (-2.71 %) |
May 29 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.37 | 2,989 | 22,029 | 1,768,897 | 1.8 M to 1.8 M (-0.17 %) |
May 29 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.36 | 17,495 | 128,691 | 1,771,886 | 1.8 M to 1.8 M (-0.98 %) |
May 29 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.36 | 8,206 | 60,431 | 1,789,381 | 1.8 M to 1.8 M (-0.46 %) |
May 29 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.36 | 49,993 | 367,953 | 1,797,587 | 1.8 M to 1.8 M (-2.71 %) |
May 29 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.37 | 554 | 4,083 | 328,197 | 328.8 K to 328.2 K (-0.17 %) |
May 29 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.36 | 3,246 | 23,877 | 328,751 | 332 K to 328.8 K (-0.98 %) |
May 29 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.36 | 1,522 | 11,208 | 331,997 | 333.5 K to 332 K (-0.46 %) |
May 29 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Sell | S | 7.36 | 9,275 | 68,265 | 333,519 | 342.8 K to 333.5 K (-2.71 %) |
May 01 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Option Exercise | A | 7.21 | 50,000 | 360,500 | 50,000 | |
Apr 19 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Buy | J | 0.00 | 578 | 0 | 4,052 | 3.5 K to 4.1 K (+16.64 %) |
Apr 19 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Buy | J | 0.00 | 3,474 | 0 | 3,474 | 0 to 3.5 K |
Apr 19 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Buy | J | 0.00 | 4,394 | 0 | 1,847,580 | 1.8 M to 1.8 M (+0.24 %) |
Apr 19 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Buy | J | 0.00 | 1,843,186 | 0 | 1,843,186 | 0 to 1.8 M |
Apr 19 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Buy | J | 0.00 | 81,371 | 0 | 81,371 | 0 to 81.4 K |
Apr 19 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Buy | J | 0.00 | 361,745 | 0 | 361,745 | 0 to 361.7 K |
Apr 19 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Buy | J | 0.00 | 815,058 | 0 | 815,058 | 0 to 815.1 K |
Apr 19 2007 | IDEV | Endo Pharmaceutica ... | GALE JAMES C | Director | Buy | J | 0.00 | 1,074,234 | 0 | 1,074,234 | 0 to 1.1 M |